These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19683138)

  • 1. Trastuzumab (Herceptin)-associated cardiomyopathy presented as new onset of complete left bundle-branch block mimicking acute coronary syndrome: a case report and literature review.
    Tu CM; Chu KM; Yang SP; Cheng SM; Wang WB
    Am J Emerg Med; 2009 Sep; 27(7):903.e1-3. PubMed ID: 19683138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiotoxicity of trastuzumab of significance in the adjuvant treatment of breast cancer].
    Menke-van der Houven van Oordt CW; Fliervoet HJ; Mandigers CM; van Spronsen DJ
    Ned Tijdschr Geneeskd; 2008 Jan; 152(3):158-63. PubMed ID: 18271465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility.
    Telli ML; Hunt SA; Carlson RW; Guardino AE
    J Clin Oncol; 2007 Aug; 25(23):3525-33. PubMed ID: 17687157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment.
    Ewer MS; Vooletich MT; Durand JB; Woods ML; Davis JR; Valero V; Lenihan DJ
    J Clin Oncol; 2005 Nov; 23(31):7820-6. PubMed ID: 16258084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study.
    Wadhwa D; Fallah-Rad N; Grenier D; Krahn M; Fang T; Ahmadie R; Walker JR; Lister D; Arora RC; Barac I; Morris A; Jassal DS
    Breast Cancer Res Treat; 2009 Sep; 117(2):357-64. PubMed ID: 19082707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged trastuzumab therapy in a patient with recurrent breast cancer and anthracycline-induced cardiac failure.
    Walji N; Bhatt L; Dhallu S; Fernando IN
    Breast; 2008 Aug; 17(4):423-5. PubMed ID: 18479923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trastuzumab-associated cardiotoxicity.
    Keefe DL
    Cancer; 2002 Oct; 95(7):1592-600. PubMed ID: 12237930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advanced sequelae of apical hypertrophic cardiomyopathy: report of two cases with wall motion abnormalities].
    Kusukawa J; Suwa M; Nakayama Y; Hirota Y; Kawamura K; Adachi I; Akagi H
    J Cardiol; 1988 Mar; 18(1):259-69. PubMed ID: 3221316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trastuzumab-induced cardiomyopathy.
    Guglin M; Cutro R; Mishkin JD
    J Card Fail; 2008 Jun; 14(5):437-44. PubMed ID: 18514938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of trastuzumab-related cardiac dysfunction.
    Carver JR
    Prog Cardiovasc Dis; 2010; 53(2):130-9. PubMed ID: 20728700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the recovery of trastuzumab-related cardiac dysfunction.
    Gillham CM; Chalmers AC; Plowman PN
    Clin Oncol (R Coll Radiol); 2001; 13(2):146. PubMed ID: 11373881
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer.
    Suter TM; Cook-Bruns N; Barton C
    Breast; 2004 Jun; 13(3):173-83. PubMed ID: 15177418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31.
    Tan-Chiu E; Yothers G; Romond E; Geyer CE; Ewer M; Keefe D; Shannon RP; Swain SM; Brown A; Fehrenbacher L; Vogel VG; Seay TE; Rastogi P; Mamounas EP; Wolmark N; Bryant J
    J Clin Oncol; 2005 Nov; 23(31):7811-9. PubMed ID: 16258083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular tachycardia with QRS configuration similar to that in sinus rhythm and a myocardial origin: differential diagnosis with bundle branch reentry.
    Guo H; Hecker S; Lévy S; Olshansky B
    Europace; 2001 Apr; 3(2):115-23. PubMed ID: 11333048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early warning system for pulmonary fluid status monitoring in terminal heart failure].
    Wedekind H; Möller K
    Dtsch Med Wochenschr; 2007 Mar; 132(11):555-9. PubMed ID: 17342631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.
    Suter TM; Procter M; van Veldhuisen DJ; Muscholl M; Bergh J; Carlomagno C; Perren T; Passalacqua R; Bighin C; Klijn JG; Ageev FT; Hitre E; Groetz J; Iwata H; Knap M; Gnant M; Muehlbauer S; Spence A; Gelber RD; Piccart-Gebhart MJ
    J Clin Oncol; 2007 Sep; 25(25):3859-65. PubMed ID: 17646669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The surface electrocardiogram predicts risk of heart block during right heart catheterization in patients with preexisting left bundle branch block: implications for the definition of complete left bundle branch block.
    Padanilam BJ; Morris KE; Olson JA; Rippy JS; Walsh MN; Subramanian N; Vidal A; Prystowsky EN; Steinberg LA
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):781-5. PubMed ID: 20132380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Unstable angina pectoris in intermittent left bundle branch block].
    Albert S; Flury G
    Praxis (Bern 1994); 1997 Nov; 86(47):1868-72. PubMed ID: 9480506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study.
    Bengala C; Zamagni C; Pedrazzoli P; Matteucci P; Ballestrero A; Da Prada G; Martino M; Rosti G; Danova M; Bregni M; Jovic G; Guarneri V; Maur M; Conte PF;
    Br J Cancer; 2006 Apr; 94(7):1016-20. PubMed ID: 16570045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review.
    Shrim A; Garcia-Bournissen F; Maxwell C; Farine D; Koren G
    Reprod Toxicol; 2007 Jun; 23(4):611-3. PubMed ID: 17399946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.